Skip to main content
Premium Trial:

Request an Annual Quote

Short Reads: Mar 1, 2002

Premium

Elliott Sigal, who joined Bristol-Myers Squibb as VP of applied genomics and worked his way up to senior vice president of drug discovery and exploratory development, has been named senior VP of global clinical and pharmaceutical development.

 

MDS Proteomics announced the hiring of two new VPs of drug discovery: Gregg Morin, previously with Geron, will be based at the Toronto headquarters; and Mark Scheideler, from GlaxoSmithKline, will work out of Odense, Denmark.

 

The Automation Partnership announced that Rod Westrop will be its new genomics business manager. Westrop has worked with Jarvis Porter Healthcare, Lark Technologies, and Amersham Pharmacia in the UK.

 

Bioinformatics firm Xpogen names Michael Fahy from Blackstone Computing VP of sales, and Robert Halpern, most recently of Fact City, to vice president of business development.

 

Christian Marcazzo makes a transition from his role in product management at Lion Bioscience to strategic business development.

 

Stephen Peroutka, formerly chief medical officer at Collabra Pharma, joins Deltagen as vice president of clinical research. Peroutka has also worked at Genentech and Spectra Biomedical.

HUPO’s players are coming out of the woodwork. Under the leadership of prez Samir Hanash of U. of Michigan Med School, four new committees got their chairs: Julio Celis of the Danish Cancer Society heads up the meetings committee; Matthias Mann, chief proteomics officer of MDS Proteomics, leads the informatics group; Richard Simpson from the Ludwig Institute for Cancer Research chairs the technology and resources committee; and Ian Humphery-Smith, COO of Glaucus Proteomics, leads the business development committee.

 

Frances Heller heads to Hayward, Calif.’s Signature BioScience, where she’ll be vice president of corporate development and legal affairs. Heller comes to Signature from a similar position at Zyomyx.

 

Speaking of legal affairs, proteomics firm ActivX Biosciences hires Nancy Dahl, formerly with Amylin Pharmaceuticals, as VP and general counsel.

 

Attempting to reorganize, Canadian firm Genomics One fired Sydney Abrahams and Andrea Abrahams. President and CSO Suzanne Lebel will fill their shoes for the time and would not say whether further dismissals were expected during the restructuring.

 

Sadly, Montegu Black, the founding chairman of Canadian proteomics firm Syn X Pharma, died of cancer at 61.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.